![]()
Reuters
![]()
Roche drug succeeds in hard-to-treat form of multiple sclerosisReutersSwitzerland's Roche said on Monday its experimental drug ocrelizumab had proved effective against hard-to-treat primary progressive multiple sclerosis in a keenly awaited final-stage clinical trial. The injectable antibody medicine is the first product ...GENENTECH'S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFFICACY IN ...Business Wire (press release)Roche drug succeeds in hard-to-treat form of MSYahoo NewsRoche's ocrelizumab first investigationa ...The FINANCIALall 9 news articles »